Researchers constantly seek innovative approaches to tackle cancer. One concept gaining traction is antifragility, a property where systems not only withstand stress but improve because of it.
Guselkumab Shows Early Symptom Improvement in UC
New data from the QUASAR phase III induction study presented at the American College of Gastroenterology (ACG) annual meeting demonstrated early symptom improvement with guselkumab